Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RALLY-IBD: A Phase 2 Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of DISC-0974 in Participants With Inflammatory Bowel Disease and Anemia of Inflammation.

Next Previous
Trial Profile

RALLY-IBD: A Phase 2 Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of DISC-0974 in Participants With Inflammatory Bowel Disease and Anemia of Inflammation.

Status: Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Feb 2026

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs DISC 0974 (Primary)
  • Indications Anaemia; Inflammatory bowel diseases
  • Focus Therapeutic Use
  • Acronyms RALLY-IBD
  • Sponsors Disc Medicine

Most Recent Events

  • 27 Jan 2026 Status changed from planning to not yet recruiting.
  • 12 Jan 2026 According to a Disc Medicine media release,Updated data from this trial expected in H2 2026, followed by an End of Phase 2 Meeting.
  • 21 Nov 2025 According to a Disc Medicine media release, company plans a phase II trial for Anemia and Inflammatory bowel diseases in 1Q of 2026.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top